中國企業在2023AACR.上披露的產品

●以anti-PDL1/CD3/4-1BB為基礎的多特異性抗體;anti-

HER3/EGFRADC;anti-HER2ADC;anti-TROP2ADC等

●

anti-CD25單抗;anti-B7-H3單抗;anti-EGFR/c-MetADC;anti-IL-11RA單抗;anti-Muc1/EGFR雙抗;anti-AMHR2單抗ROS1/ALK/Trk抑制劑;CDK7抑制劑;CDK2/4/6抑制劑;EGFRexon20/HER2exon20抑制劑;YAP/TEAD抑制劑;.RET抑制劑

●

anti-PDL1/TGF-β雙抗;CD73抑制劑;HIF-2a抑制劑;IDH1/2抑制劑;TEAD棕櫚?；种苿?br />
●

SOS1抑制劑;anti-BCMA/CD3/GPRC5D三特異性抗體:anti-Muc17/CD3雙特異性抗體;POLQ抑制劑

DGKA抑制劑;CDK12抑制劑;USP1抑制劑;MAT2A抑制劑

●

anti-TROP2ADC;anti-HER2ADC;anti-HER3ADC;anti-B7-H3ADC